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Hair loss is a disease caused by aged hair follicles as a result of inter-
nal factors such as ageing and hormones, and external factors such 
as stress and environmental hormones. Once hair loss begins, it is 
progressive and irreversible, and there is currently no fundamental 
treatment for hair loss. The treatment options used so far include 
stimulating existing hair follicles so that new hair grows faster and 
richer, or transplanting new hair. Another option is to use cell ther-
apy. It has been reported that adipose-derived stem cells (ASCs) and 
their conditioned medium (CM) have hair growth effect, but results 
have been largely unsatisfactory until now. Therefore, previous 
studies have focused on enhancing the function of ASCs to promote 
hair growth.1-6 In particular, the biggest reason why ASCs and their 
CM can increase hair growth is because many growth factors are 
released from ASCs to promote hair growth. We recently studied the 
enhancement of ASC function by heparin-binding epidermal growth 
factor (EGF)-like growth factor (HB-EGF), which is one of the EGF 
family growth factors, and its hair growth effect.6 Among the other 
members of the EGF family, EREG has also stimulated ASC motility, 
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Objectives: EREG (epiregulin), a member of the epidermal growth factor (EGF) fam-
ily, plays a role in inflammation, wound healing, normal physiology and malignancies. 
However, little is known about its function on hair growth.
Materials and Methods: Cell growth assay, QPCR and immunostaining were carried 
out. Telogen-to-anagen transition and organ culture were conducted. ROS level was 
monitored by staining DCFDA.
Results: We investigated the hair inductive effect of EREG and the mechanism of 
stimulation on DPCs and ORS cells during hair cycling. Whereas EREG promoted hair 
growth, EREG knockdown inhibited hair growth as evidenced by telogen-to-anagen 
transition and organ culture models. EREG was expressed in epidermal cells including 
ORS	cells	 in	vivo.	EREG	activated	phospho-ErbB4	 in	DPCs	during	hair	cycling	and	
stimulated	DPCs	via	ErbB4	activation	in	vitro.	In	terms	of	the	underlying	mechanism,	
reactive oxygen species (ROS) played a key role in DPC stimulation. EREG also acti-
vated phospho-EGF receptor (EGFR) in epidermal cells including matrix and ORS cells 
in vivo and stimulated ORS cells via EGFR activation in vitro.
Conclusions: EREG,	which	is	released	from	ORS	cells,	activated	EGFR	and	ErbB4	on	
epidermal cells and DPCs during hair cycling, respectively. As a result, EREG stimu-
lated epidermal cells a positive feedback and DPCs via regulating ROS generation for 
hair growth. Therefore, EREG therapy may be a novel solution for hair loss treatment.
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and EREG-pre-conditioned ASC and its CM enhanced hair growth 
(data not shown). When we examined whether HB-EGF and EREG 
themselves had hair growth effect, only the subcutaneous injection 
of EREG induced hair growth. It was expected that EREG would 
probably act directly on the cells that make up the hair follicles to 
increase hair growth.
The mature growth factors bind to members of the EGF receptor 
(ErbB) family of receptor tyrosine kinases (RTKs). This family con-
sists	of	EGFR,	ErbB2,	ErbB3	and	ErbB4.	Among	them,	EREG	has	a	
high	binding	affinity	for	EGFR	and	ErbB4.7 A binding of ligand with 
ErbB receptors can either homodimerize or heterodimerize with a 
different member of the ErbB family. Receptor dimerization enables 
the tyrosine phosphorylation of one receptor by the other. This 
cross-phosphorylation creates binding sites for effector proteins, 
thereby enabling the receptors to serve numerous signalling cas-
cades, most notably the Raf/Ras/mitogen-activated protein kinase 
signalling (MAPK) and the phosphoinositide 3 kinase (PI3K)/Akt 
pathway.8,9 The network of EGF family and ErbB receptors regu-
lates the proliferation, differentiation, inflammation, wound healing 
and function of numerous tissues in humans, and deregulated sig-
nalling of this network is a hallmark of several different human ma-
lignancies.10,11 Recently, it was reported that human EREG (hEREG) 
treatment induced hair shaft elongation regulating keratinocyte pro-
liferation.12 However, investigation of the mechanisms of how EREG 
induces hair growth is still required. Therefore, the aim of this study 
is to investigate the function of EREG and the associated mechanism 
during hair cycling.
2  | MATERIAL S AND METHODS
2.1 | Cell culture
Human dermal papilla cells (DPCs), purchased from PromoCell (#C-
12071), were cultured in follicle DPC medium with supplement mix 
(PromoCell) and 0.1% anti-antibiotics (Gibco). After informed consent 
was obtained, human outer root sheath cells (ORSs) were isolated 
(Yonsei	University	College	of	Medicine,	4-2018-0141).	Human	hair	
follicle was extracted, and the ORS part was cultured for 2-3 days in 
a culture dish containing DPC medium with supplement mix. Next, 
proliferating cells were subcultured with ORS medium. The ORS was 
cultured in EpiLife medium (Gibco) with EpiLife™ Defined Growth 
Supplement (EDGS; Gibco) and 1% penicillin/streptomycin (Gibco). 
DPCs	and	ORSs	for	all	experiments	were	used	at	passages	3-4	and	
1-2, respectively. All cells were maintained at 37°C in a humidified 
5% CO2 incubator.
2.2 | Mouse telogen-to-anagen induction
The mice were maintained and anesthetized according to a protocol 
approved by the US Pharmacopoeia and the Institutional Animal Care 
and Use Committee of Yonsei University (IACUC-201712-681-02). 
The dorsal region of 7-week-old male C3H/HeN mice in the telo-
gen stage of the hair cycle was shaved and depilated using an elec-
tric shaver, with special care taken to avoid damaging the bare 
skin. Then, 100 ng/mL of EREG (PeproTech) was injected daily 
into the dorsal skin of the shaved mice. Negative control or siRNA 
for	 EREG	 (Bioneer;	 480	 pmol/1	 mice)	 was	 injected	 with	 in	 vivo-
JetRNA	 (Polyplus	Transfection,	 Inc)	 into	 the	dorsal	 skin	of	 shaved	
mice for a total of four times. For EREG-treated DPC injection ex-
periment,	4	× 104 of the control DPC or preconditioned DPC with 
EREG	(20	ng/mL)	for	4	days	were	injected	into	the	dorsal	skin	of	the	
shaved mice. After the mice was first shaved, the actual length of 
the shaved part was measured. Almost all mice were shaved with 
size of approximately 2 ×	4.3	cm,	and	only	the	weight	of	new	hair	in	
the shaved area was measured after sacrifice. Any darkening of the 
skin (indicative of hair cycle induction) was carefully monitored using 
image capture. After approximately 16-18 days, the dorsal hair was 
shaved and weighed to estimate growth rate, and the dorsal skin was 
analysed using HE staining and immunostaining.
3  | RESULTS
3.1 | EREG induces hair growth in vivo
In contrast to HB-EGF-preconditioned ASCs, which promote hair 
growth in vivo, thereby stimulating ASC motility,6 direct injection of 
HB-EGF itself did not have a hair growth effect (Figure S1). However, 
the subcutaneous injection of EREG promoted telogen-to-anagen in-
duction (Figure 1A) and the length of mouse vibrissa and pig skin hair 
follicles (Figure 1B,C and Figure S2). To further confirm the hair pro-
motion effect of EREG, we investigated whether EREG knockdown 
would have an opposite effect on hair growth. The reduced expres-
sion of EREG in EREG siRNA-injected mice was detected in the 
epidermis and ORS cells compared to that of negative control mice 
(Figure S3). Indeed, EREG knockdown induced an opposite effect on 
hair growth as evidenced by telogen-to-anagen transition (Figure 1E) 
and organ cultures (Figure 1D,F and Figure S2). These results sug-
gested that EREG is capable of promoting hair growth in vivo.
3.2 | EREG was expressed in epidermal cells 
including ORS cells during hair cycling in vivo
Next, we investigated the expression pattern of EREG during hair cy-
cling. To do this, we examined EREG expression during anagen, cata-
gen	and	telogen	(4-7	weeks)	stages.	EREG	was	expressed	strongly	in	
epidermal cells including ORS cells (Figure 2A), and this expression was 
co-stained with keratin17, a marker for ORS cells, at the anagen stage 
(Figure	2A,	a-a‴).	The	expression	of	EREG	was	not	detected	in	the	DP	
region at anagen and early catagen (Figure 2A, a-b'''). The expression of 
EREG is obviously higher during the anagen stage and lower during the 
telogen stage; this is also confirmed by monitoring the expression in-
tensity during hair cycle (Figure 2A,B). The very weak EREG expression 
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was detected in hair germ cells and bulge region cells, which are the 
cells that will later differentiate ORS, at telogen stage, not in the DP 
region (Figure 2A, d-d'''). The strong EREG expression in ORS cells was 
also confirmed by checking the mRNA expression level between DPCs 
and ORS cells in vitro (Figure 2C). These results suggested that EREG is 
mainly expressed and secreted from epidermal cell including ORS cells.
3.3 | Activation of EREG receptor stimulated ORS 
cells and DPCs differentially in vivo
Among the ErbB family of receptors, EREG has a high binding af-
finity	 to	 EGFR	 and	 ErbB4.13 To determine where the activation of 
EREG receptor occurred and which receptor binds to EREG in vivo, 
we	investigated	the	expression	of	phospho-EGFR	or	phospho-ErbB4	
after subcutaneous injection of EREG (Figure 3A). The expression of 
phospho-EGFR was detected in ORS cells of entire hair follicles, and a 
stronger expression was detected in matrix cells 15-20 min after EREG 
injection at the anagen stage (Figure 3B, a-a''). The expression of phos-
pho-EGFR was also detected in hair germ cells and bulge region cells 
at telogen stage (Figure 3B, b-b''). No phospho-EGFR-positive cell was 
detected in DP cells during anagen and telogen stages (Figure 3B, a-b''). 
EREG binds to EGFR mainly on matrix cells and ORS cells at anagen, 
and hair germ cells and bulge region cells at telogen. These results sug-
gested that EREG-EGFR activation occurred on matrix cells and ORS 
cells at anagen, and hair germ cells and bulge cells at telogen.
F I G U R E  1   EREG promotes hair growth in vivo and ex vivo. A, Human recombinant EREG (100 ng) was injected into the dorsal skin 
of	shaved	7-wk-old	mice.	Images	were	captured,	and	hair	weight	was	measured	14	d	later.	Skin	section	was	analysed	using	haematoxylin	
and eosin (HE) staining, and the number of mature hair follicles (HF) was measured. Hair follicle with Ki67+ matrix cells was shown by 
immunostaining. Asterisks indicate hair follicles with Ki67+ matrix cells (n =	4	per	group).	All	error	bars	indicate	the	standard	error	of	the	
mean (SEM); B, EREG (5 and 20 ng) increased the length of mouse vibrissal hair follicles compared with the control ex vivo; C, EREG (20 ng) 
increased the length of pig skin hair follicles compared with the control ex vivo; D, F, EREG siRNA reduced the length of mouse vibrissal and 
pig skin hair follicles compared with the negative control ex vivo; E, EREG siRNA was injected into the dorsal skin of shaved 7-wk-old mice. 
Images were captured, and hair weight was measured 16 d later. Skin section was analysed using HE staining, and the number of mature 
HF, hair follicle with Ki67+ matrix cells, was shown by immunostaining. Asterisks indicate hair follicles with Ki67+ cells in the cortex regions. 
*P < .05, **P < .01, ***P < .001. Three independent experiments were conducted for all data points. All scale bars indicate 10 μm
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Meanwhile,	 a	 strong	 expression	 of	 phospho-ErbB4	 was	 de-
tected in DPCs 20 minutes after EREG injection, and not in matrix 
and ORS cells at anagen stage (Figure 3B, c-c''). A strong expression 
of	phospho-ErbB4	was	also	detected	in	DPCs,	and	a	relatively	weak	
expression was observed in hair germ cells and bulge region cells at 
telogen	(Figure	3B,	d-d'').	These	results	suggested	that	EREG-ErbB4	
activation occurred mainly in DPCs during hair cycling. All these 
data suggested that secreted EREG from epidermal cells including 
F I G U R E  2   EREG was expressed in ORS cells. A, The strong EREG expression (green) was observed in ORS cells (arrow), which is co-
stained with cytokeratin17 (K17, red) at anagen stage. On the contrary, a very weak EREG expression was also observed in ORS cells at 
telogen stage (c–d'''). A very faint EREG expression was detected in hair germ and bulge cells, which will later become ORS cells (d–d'''). 
Any EREG expression was not detected in DPC (arrow head); B, the intensity of EREG expression was monitored during hair cycling using 
Image	J	program;	and	C,	the	expression	level	of	EREG	was	compared	in	dermal	papilla	cells	(DPCs)	and	ORS	cells.	*P < .05, **P < .01. Three 
independent experiments were conducted for all data points. All scale bars indicate 10 μm
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ORS	cells	might	bind	to	EGFR	on	matrix	and	ORS	cells,	and	ErbB4	on	
DPCs may thus transduce the signal for hair growth.
3.4 | Activation of EREG-ErbB4 stimulated DPCs
As	 EREG	 phosphorylated	 ErbB4	 on	 DPCs	 in	 vivo,	 we	 investigated	
whether	EREG	can	stimulate	DPCs	via	ErbB4	activation	in	vitro.	First,	the	





also stimulated DPCs, as evidenced by the proliferation and expression 
level of DPC marker genes. EREG dose-dependently increased DPC pro-
liferation	by	up	to	2-fold	(Figure	4C)	and	increased	the	mRNA	expression	
level of DPC marker genes such as CD133, ALP (alkaline phosphatase), 
CORIN and NES	(nestin)	(Figure	4D).	In	particular,	when	ALP	staining	was	
performed to check the activity of ALP, the number of ALP-positive cells 
was	increased	after	EREG	treatment	(Figure	S4).	Moreover,	EREG-pre-
conditioned DPCs promoted hair growth effect significantly in vivo evi-
denced by hair weight, the number of hair follicle and hair follicle with 
Ki67+ matrix region (Figure S5) suggesting stimulated DPCs by EREG 
promoted hair growth. All of these results indicated that EREG stimu-
lated DPCs thereby promoting hair growth.
To elucidate whether the stimulation of DPCs by EREG was caused by 
ErbB4	activation,	we	reduced	the	ErbB4	mRNA	level	using	ErbB4	knock-
down.	The	results	confirmed	that	the	expression	level	of	ErbB4	mRNA	was	
F I G U R E  3   Differential activation 
of EREG receptors on keratinocytes 
including matrix and ORS cells, and 
DPCs. A, Schematic diagram for 
monitoring of receptor phosphorylation 
after EREG subcutaneous (sc) injection. 
Phosphorylation	of	EGFR1	or	ErbB4	
was monitored at 15-20 min after EREG 
injection into the dorsal skin of shaved 
mice; B, p-EGFR expression was observed 
in keratinocytes including matrix and ORS 
cells at anagen (a-a''), and hair germ and 
bulge cells at telogen (b-b''). No p-EGFR-
positive cells were detected in DPCs. 
p-ErbB4	expression	is	shown	in	DPCs	at	
anagen	(c-c'').	Moreover,	strong	p-ErbB4	
expression in DPCs and weak expression 
in hair germ and bulge cells at telogen 
were detected (d-d''). All scale bars 
indicate 10μm
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reduced	after	treatment	with	ErbB4	siRNA	(Figure	4E).	Whereas	a	strong	






3.5 | EREG increased reactive oxygen species levels 
by regulating the expression of NADPH oxidase 4 
in DPCs
Previous studies have shown that hypoxia improves hair induc-
tivity	 of	 DPCs	 via	 nuclear	 NADPH	 oxidase	 4	 (NOX4)-mediated	
reactive oxygen species (ROS) generation.14 Therefore, to investi-
gate whether the stimulation of DPCs by EREG is associated with 
increased cellular ROS levels, we examined the cellular ROS lev-
els	 after	 EREG	 treatment	 using	 2′,7′-dichlorofluorescin	 diacetate	
(DCFDA) staining. EREG treatment significantly increased the cel-
lular ROS level (Figure 5A); however, this increase is not attributable 
to the increased ROS production in mitochondria at least (Figure S6). 
This is because when EREG-treated DPCs were co-stained with 
MitoTracker,	which	 is	a	mitochondria	marker,	and	MitoSOX,	which	
is	an	ROS	indicator	 in	mitochondria,	MitoSOX	was	not	detected	in	
mitochondria.	 Rather,	 some	 of	 the	 MitoSOX	 signals	 are	 detected	
inside the nucleus. These results are in line with previous reports 
about	the	increased	NOX4	expression	in	the	nucleus,	and	not	in	mi-
tochondria of DPCs.14 To examine whether increased cellular ROS 
levels can regulate DPC proliferation by EREG, cell proliferation 




expression was detected 15 min after 
EREG (20 ng/mL) treatment in more than 
95% of DPCs analysed, whereas it was 
not detected in ORS cells after EREG 
treatment; C, cell growth after EREG 
treatment (5, 20 ng/mL) was monitored in 
DPCs; D, expression of DPC marker genes, 
CD133, ALP, CORIN, NES, was examined 
using qPCR after EREG treatment in 
DPCs;	E,	expression	level	of	ErbB4	mRNA	




after EREG treatment (20 ng/mL); and 
G, cell growth after EREG treatment 
was monitored in negative control- and 
ErbB4	siRNA-treated	DPCs.	*P < .05, 
**P < .01, ***P < .001. Three independent 
experiments were conducted for all data 
points. All scale bars indicate 10 μm
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was measured after diphenyleneiodonium (DPI, a NADPH oxidase 
inhibitor) treatment. DPI treatment attenuated the increase of DPC 
proliferation by EREG (Figure 5B), suggesting that increase of DPC 
proliferation by EREG is attributable to NADPH oxidase level. To 
know which NADPH oxidase is related with the above result, the 
expression	 levels	of	all	NOX	families	 (NOX1-NOX5)	were	checked	
after	EREG	treatment.	NOX1,	NOX2,	NOX3	and	NOX5	were	not	de-
tected in both EREG-treated and EREG-untreated DPCs (Figure S7). 
In	effect,	only	 the	expression	 level	of	NOX4	 is	 regulated	by	EREG	
treatment (Figure 5C). These results are consistent with previous 
results	 indicating	 that	 NOX4	 is	 a	 key	 regulator	 in	 increasing	 ROS	
levels	 among	other	NOX	 families.14	Next,	 the	 role	of	NOX4	 in	 in-
creased cell proliferation and ROS level by EREG was investigated 
using	NOX4	knockout	DPCs.	Results	showed	that	cell	proliferation	
and	ROS	level	in	NOX4	knockout	DPCs	were	not	increased	by	EREG	
treatment, whereas EREG increased cell proliferation and ROS level 





increased by EREG in the negative control group, whereas the expres-
sion	level	of	NOX4	mRNA	was	not	increased	by	EREG	in	ErbB4	siRNA	
(Figure	5F).	The	ROS	level	was	significantly	decreased	in	ErbB4	knock-
down DPCs and was not increased by EREG treatment (Figure 5G). 
In contrast, EREG increased the ROS level in negative control DPCs 
(Figure	5G).	These	results	indicate	that	activation	of	EREG-ErbB4	in-
creased	the	production	of	ROS	by	regulating	NOX4	expression.
3.6 | Activation of EREG-EGFR stimulated ORS cells
As EREG phosphorylated EGFR in matrix and ORS cells in vivo 
(Figure 3B), we investigated whether EREG can stimulate ORS cells 
in vitro. First, the expression level of EGFR mRNA was significantly 
increased in ORS cells compared with that in DPCs (Figure 6A). 
Phospho-EGFR expression was detected in ORS cells 15 minutes 
after EREG treatment (Figure 6B). EREG also stimulated ORS cells 
as evidenced by proliferation and migration (Figure 6C,D). These re-
sults indicated that EREG stimulated ORS cells.
F I G U R E  5   EREG increase ROS levels 
by	regulating	NOX4	expression	in	DPCs.	
A, Cellular ROS levels were monitored 
after EREG treatment using DCFDA 
staining; B, increased cell growth by 
EREG was monitored after DPI treatment; 
C,	expression	level	of	NOX4	mRNA	
was examined after EREG treatment 
using qPCR reaction; D, cell growth 
after EREG treatment was monitored 
in	NOX4	knockout	DPCs;	E,	ROS	levels	
were monitored after EREG (20 ng/




DPCs using qPCR; and G, ROS levels 
were monitored after EREG (20 ng/
mL) treatment using DCFDA staining 
in	ErbB4	knockdown	DPCs.	*P < .05, 
**P < .01, ***P < .001. Three independent 
experiments were conducted for all data 
points. All error bars indicate the SEM. All 
scale bars indicate 10 μm
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To elucidate whether stimulation of ORS cells by EREG 
was caused by EGFR activation, we reduced the level of EGFR 
mRNA using EGFR knockdown. The reduced expression level of 
EGFR mRNA was confirmed in EGFR siRNA-treated ORS cells 
(Figure 6E). Interestingly, the expression level of EGFR mRNA 
was upregulated by EREG, suggesting that EGFR expression 
is positively regulated by EREG. EGFR knockdown eliminated 
stimulatory effect of EREG (Figure 6F,G). These results sug-
gested that EREG binds to EGFR in ORS cells, thereby stimulat-
ing ORS cells.
As EREG is expressed in keratinocytes including epidermal and 
ORS cells in vivo (Figure 2), EREG mRNA expression is knockdown 
using EREG siRNA in vitro. The reduced expression level of EREG 
mRNA was confirmed in EREG siRNA-treated ORS cells (Figure 6H). 
EREG knockdown decreased ORS cell proliferation and migration 
(Figure	6I,J).	These	results	suggested	that	the	released	EREG	from	
epidermal and ORS cells can stimulate ORS cells again as a positive 
feedback mechanism.
4  | DISCUSSION
Whereas direct injection of HB-EGF was not able to induce pro-
motion of hair growth (Figure S1), direct injection of EREG signifi-
cantly promoted hair growth (Figure 1). A recent study revealed that 
hEREG induced elongation of hair shaft stimulating keratinocytes.12 
However, not much is known about the molecular mechanism of 
how EREG promotes hair growth. Our study examined how EREG 
can promote hair growth in vivo and ex vivo using human recombi-
nant or knockdown of EREG. The present study also further inves-
tigated EREG expression in keratinocytes including epidermis and 
ORS cells, and differential activation and stimulation of EREG-EGFR 
and	EREG-ErbB4	on	ORS	 cells	 and	DPCs,	 respectively.	Moreover,	
the	activation	of	EREG-ErbB4	increases	NOX4	expression,	thus	con-
trolling the ROS level in DPCs.
There are controversial reports on the hair growth-promot-
ing effect of growth factors. For example, recombinant plate-
let-derived growth factor (rhPDGF)-A and rhPDGF-B have been 
F I G U R E  6   EREG stimulated ORS cells 
via activation of EGFR. A, mRNA level of 
EGFR was compared with DPCs and ORS 
cells in vitro; B, p-EGFR expression was 
detected 15 min after EREG (20 ng/mL) 
treatment in DPCs. Scale bar indicates 
10 μm; C and D, cell growth and migratory 
ability after EREG treatment (20 ng/
mL) were monitored in ORS cells; E, 
expression level of EGFR mRNA was 
checked between negative control for 
siRNA- and EGFR siRNA-treated ORS 
cells; F and G, cell growth and migratory 
ability after EREG treatment (20 ng/mL) 
were monitored in negative control and 
EGFR knockdown ORS cells; H, expression 
level of EREG mRNA was checked 
between negative control for siRNA- and 
EREG siRNA-treated ORS cells; and I 
and	J,	cell	growth	and	migratory	ability	
were monitored in negative control and 
EGFR knockdown ORS cells. *P < .05, 
**P < .01, ***P < .001. Three independent 
experiments were conducted for all data 
points
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shown to induce anagen transition and increase the proliferation 
of DPCs. However, EGF mimetics inhibited hair growth in an an-
imal model. Keratinocyte growth factor and EGF signalling inhib-
ited hair follicle induction,15 and the EGFR decreased stathmin 1 
and triggered catagen entry in the mouse.16 Our results were also 
controversial because direct injection of HB-EGF did not affect 
hair growth promotion at all (Figure S1), whereas EREG directly 
induced hair growth promotion (Figure 1). These results were con-
sistent with the report of another research group, which noted 
that PDGF-AA-inducible EREG promotes elongation of human hair 
shaft by enhancing proliferation and differentiation of follicular 
keratinocytes.12 This marks the first evidence that EREG has hair 
growth-promoting effects directly. However, their study over-
looked EREG-receptor activation in DPCs and the role of DPCs 
as major storage to control the proliferation and differentiation of 
hair follicle stem cells and matrix cells. Our study further demon-
strated	that	EREG	phosphorylated	ErbB4	on	DPCs	in	vivo,	and	this	
EREG-ErbB4	 activation	 stimulated	 DPCs	 by	 regulating	 the	 ROS	
level	through	NOX4	expression.	This	represents	the	first	evidence	
that	 one	member	 of	 the	 EGF	 family	 stimulated	DPCs	 via	 ErbB4	
during hair cycling. In agreement with their report, our results also 
showed that EREG activated EGFR on keratinocytes including ORS 
cells in vivo. However, our results further revealed that a strong 
phosphorylated EGFR (p-EGFR) expression occurred in matrix cells 
at anagen, suggesting that EREG-EGFR activation may stimulate 
matrix cell proliferation for hair growth during the anagen stage. 
We may need to further see the relationship between MAPK/PI3K 
signalling and EREG-EGFR activation in matrix cells, but we sus-
pect that these signals may be involved in matrix cell proliferation. 
It has been reported that the EGF family triggered activation of 
the Ras-Raf-MAPK and PI3K pathways,9 which are representative 
signalling for cell proliferation.
It has been reported that EREG had a binding affinity for both 
EGFR	and	ErbB4.10,13 The ErbB family comprises four homologous 
RTKs.	 The	 EGFR,	 ErbB3	 and	 ErbB4	 receptors	 can	 bind	 with	 li-
gands, whereas ErbB2 lacks a ligand binding domain and functions 
as	a	preferred	co-receptor.	ErbB4	is	the	only	ErbB	family	member	
that binds all four neuregulins, as well as EGF, EREG and HB-EGF 
that had originally been identified as EGFR ligands.13 There are 
published reports about stimulation of DPCs by growth factor 
and receptor expression of some growth factors on DPCs. The 
intradermal adipocyte precursor cells activated PDGF-PDGFR sig-
nalling in the DP in a dynamic manner.17 Our results also showed 
that	EREG	phosphorylated	ErbB4	in	DPCs	and	stimulated	DPCs,	as	
indicated by cell proliferation and the expression of DPC marker 
genes	in	vitro	(Figure	4).
Hair follicle growth is dependent on the interaction between 
epithelial precursor cells that reside in the bulge region and 
DPCs.18,19 DPCs provide the instructive signals required to in-
duce the proliferation and initiation of anagen follicle growth of 
matrix cells as well as epithelial bulge stem cells.20,21 Recent work 
has shown the identification of epithelial matrix progenitors within 
DPCs and its influence on the proliferative characteristic of the 
mature hair follicles, thereby indirectly regulating hair growth.22 
Interestingly, although DPCs are responsible for controlling hair 
growth, it is not well understood how these cells are maintained 
or replenished, because cells within the DP rarely undergo mitotic 
division.23 Indeed, bromodeoxyuridine (BrdU) labelling or Ki67 
staining trials revealed that proliferating DPCs were not detected 
in vivo. However, many previous studies have shown that DPC pro-
liferation and the increased expression of DPC marker genes had a 
significant correlation relationship with hair growth promotion ef-
fect.6,24 Our previous study also revealed that DPCs placed under 
hypoxic conditions showed increased proliferation and expression 
of DPC marker gene, and these DPC-injected mice showed consid-
erable hair growth in vivo.14
It has been reported that PDGF-D mediated increased prolifera-
tion, migration and paracrine effects on ASCs via ROS generation.3 
Although EGF mimetic reportedly affected the proliferation and dif-
ferentiation of ASCs and mediated these functions via ROS genera-
tion in other cell type,6 this is the first evidence showing that EREG 
increases the mitogenic and hair growth-promoting effects in DPCs 
via ROS generation. The ROS generating system was further exam-
ined, and EREG increased cellular ROS level, but did not lead to ROS 
generation in the mitochondria of DPC (Figure S7). The expression of 
Nox4	was	high	in	the	nucleus	of	DPCs,14	and	Nox4	silencing	attenu-
ated	the	ROS	level,	NOX4	expression	and	DPC	stimulation	by	EREG,	
suggesting that EREG increased ROS generation through nuclear 
NOX4	expression	in	DPCs.	It	was	reported	that	amphiregulin	(AREG)	
and	HB-EGF	have	 the	same	effect	at	 increasing	NOX1	expression	
in smooth muscle cells.25 Although the scope of our study does not 
specifically cover more detailed transcriptional data, this marks the 
first	evidence	that	EREG	regulates	NOX4	expression.	Because	EREG	
is a releasing growth factor, further research is warranted to deter-
mine	which	 transcription	 factors	are	 involved	 in	NOX4	expression	
by EREG.
In summary, EREG induced hair growth as evidenced by recom-
binant and knockdown of EREG in vivo. EREG was expressed in ke-
ratinocytes including epidermal and ORS cells during hair cycling, 
and its expression level was high in anagen compared to telogen. 
Differential	activation	of	EREG-EGFR	and	EREG-ErbB4	occurred	on	
keratinocytes including matrix/ORS cells and DPCs, respectively, 
during hair cycling. EREG-EGFR activation stimulated ORS cells as 
a	 positive	 feedback	 and	 EREG-ErbB4	 activation	 stimulated	 DPCs	
regulating	ROS	generation	and	NOX4	expression.	Therefore,	EREG	
therapy may offer a novel solution for hair loss treatment.
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